What This Document Is
This document is a review guide for the second exam in Boston College’s NURS 2204 Pharmacology and Nutrition Therapies course. It focuses on key considerations for pharmacology related to pregnancy, breastfeeding, pain management, and opioid medications. The review covers potential adverse drug reactions (ADRs) during pregnancy, updated FDA guidelines, and the physiological basis of pain and opioid therapy.
Why This Document Matters
This review is designed for students preparing for an exam on critical pharmacological concepts related to vulnerable populations – pregnant and breastfeeding individuals – and the management of pain. It’s intended to help students consolidate their understanding of drug effects during these physiological states and the safe and effective use of opioid analgesics. Successful navigation of these topics is essential for providing safe and effective patient care in various clinical settings.
Common Limitations or Challenges
This review is *not* a substitute for attending lectures, completing assigned readings, or engaging with course materials. It’s a condensed overview and does not provide in-depth explanations of all concepts. It also doesn’t include practice questions or detailed case studies. Students should use this review as a starting point for focused study, not as a comprehensive learning tool.
What This Document Provides
The full review includes information on:
* Risks and considerations for medication use during pregnancy (including specific drug examples like ibuprofen, acetaminophen, and heparin).
* The impact of physiological changes during pregnancy on drug pharmacokinetics.
* FDA pregnancy risk categories and the updated Pregnancy and Lactation Labeling Rule (PLLR).
* Teratogenesis, including risk reduction strategies.
* Drug therapy considerations during breastfeeding.
* The physiology of pain and the mechanisms of opioid analgesics.
* The Controlled Substance Act and opioid scheduling.
* Specific information on morphine, including its pharmacokinetics, therapeutic uses, and adverse effects.
This preview does *not* include detailed explanations of pharmacokinetic principles, specific dosage calculations, or comprehensive lists of teratogenic drugs. It also does not contain any practice questions or case studies.